EXECUTIVE ENGAGEMENTS
POOL
13417
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1612
Interactions with Platform & by Email
PARTICIPANTS
403
Unique # Participated
VALIDATIONS
82
Responses Validated*
COMPANIES
12
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
179
EDITION
9
PRICE
USD 4950
CODE
MCP10738
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Global Biosurgery Market to Reach $16 Billion by 2026
Amid the COVID-19 crisis, the global market for Biosurgery estimated at US$11.8 Billion in the year 2020, is projected to reach a revised size of US$16 Billion by 2026, growing at a CAGR of 5.1% over the analysis period. Surgical Sealing Agents, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hemostatic Agents segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.7 Billion in 2021, While China is Forecast to Reach $2.8 Billion by 2026
The Biosurgery market in the U.S. is estimated at US$3.7 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2026 trailing a CAGR of 4.8% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
Anti-Adhesion Agents Segment to Reach US$785.3 Million by the year 2026
In the global Anti-Adhesion Agents segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$453.4 Million in the year 2020 will reach a projected size of US$661.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
SELECT PLAYERS
B. Braun Melsungen AG; BARD, A Becton, Dickinson Company; Baxter International, Inc.; Cohera Medical, Inc.; CryoLife, Inc.; Hemostasis, LLC; Integra LifeSciences Holdings Corporation; Johnson & Johnson; MAQUET Holding B.V. & Co. KG; Medtronic PLC; Pfizer, Inc.; Sanofi U.S.; Stryker Corporation
SEGMENTS
» Product (Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management, Bone Graft Substitutes)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Biosurgery Market to Witness Steady Growth |
| Table: Percentage Market Share of Worldwide Bio-Surgeries by Country: 2015 and 2022 |
| Bone Graft Substitutes to Account for Largest Share |
| North American Region to Dominate Market Growth |
| Table: Worldwide Biosurgery Market: Breakdown of Total Sales Value (in Billion USD) by Region: 2015 and 2022 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| New Approvals to Support Market Growth |
| Various Strategies from Leading Players to Bolster Market Growth |
| Rapid Growth in Ageing Population Drives Market Growth |
| Table: Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E) |
| Rise in Worldwide Surgical Procedures to Fuel Market Growth |
| Table: Total Number of Surgical Procedures Performed (in Millions) Per Annum in the US: 1981-2015 |
| Table: Total Number of Surgical Procedures Performed for Inpatients in Europe per Annum: 2001-2015 |
| Rising Incidence of Injuries due to Trauma Supports Market Growth |
| Myriad Health End-Users to Drive Market Growth |
| Table: Percentage Breakdown of Biosurgery Market Shares by Application: 2018 |
| Table: Percentage Growth Rate of Various Bio-Surgical Products in Wound-Closure Segment: 2011-2017 |
| Innovations to Spur Market Growth |
| Table: Total Sales of DermaPure: 2016-2018 |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Soft Tissue Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Soft Tissue Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Soft Tissue Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 12 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com